Hoth licenses patents to develop anti-obesity treatments
[ad_1]
Hoth licenses patents to develop anti-obesity treatments
[ad_2]
Similar Posts
Concentrix Q3 2024 Earnings Preview
Byadmin
[ad_1] Concentrix (NASDAQ:CNXC) is scheduled to announce Q3 earnings results on Wednesday, January 15th, after market close. The consensus EPS Estimate is $3.01 (+4.9% Y/Y) and the consensus Revenue Estimate is $2.44B (+2.5% Y/Y). Over the last 2 years, CNXC has [ad_2]
D.R. Horton Q1 2025 Earnings Preview
Byadmin
[ad_1] D.R. Horton Q1 2025 Earnings Preview [ad_2]
Executive reshuffles: WELL, SLG and LXRX
Byadmin
[ad_1] Executive reshuffles: WELL, SLG and LXRX [ad_2]
Chino Commercial Bancorp GAAP EPS of $0.43, revenue of $4.57M
Byadmin
[ad_1] Chino Commercial Bancorp GAAP EPS of $0.43, revenue of $4.57M [ad_2]
Digital Ally files to sell 808,377 shares of common stock for holders
Byadmin
[ad_1] Digital Ally files to sell 808,377 shares of common stock for holders [ad_2]
AXS AstoÃia Inflation Sensitive EľF declares quarterly distribution of $0.0504
Byadmin
[ad_1] AXS AstoÃia Inflation Sensitive EľF declares quarterly distribution of $0.0504 [ad_2]